Molecular action of vitamin E in lipoprotein oxidation: Implications for atherosclerosis

Free Radical Biology and Medicine

Volumn 28, Issue 12, 2000, Pages 1795-1805

  Thomas, Shane R ^a   Stocker, Roland ^a  

^a HEART RESEARCH INSTITUTE   (Australia)

Author keywords

Antioxidant; Free radical; Lipid peroxidation; Low density lipoprotein; Ubiquinol 10; Vitamin C; Tocopherol

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; LIPID; LIPOPROTEIN; OXIDIZING AGENT; UBIQUINOL CYTOCHROME C REDUCTASE;

ATHEROSCLEROSIS; HUMAN; LIPID PEROXIDATION; NONHUMAN; OXIDATION; PRIORITY JOURNAL; REVIEW;

ANIMALIA;

EID: 0034659172     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5849(00)00236-7     Document Type: Article

References (78)

1. Steinberg D., Parthasarathy S., Carew T.E., Khoo J.C., Witztum J.L. Beyond cholesterol modifications of low-density lipoprotein that increase its atherogenicity . N. Engl. J. Med. 320:1989;915-924.
2. Berliner J.A., Heinecke J.W. The role of oxidized lipoproteins in atherogenesis. Free Radic. Biol. Med. 20:1996;707-727.
3. Diaz M.N., Frei B., Vita J.A., Keaney J.F. Jr. Antioxidants and atherosclerotic heart disease. N. Engl. J. Med. 337:1997;408-416.
4. Ylä-Herttuala S., Palinski W., Rosenfeld M.E., Parthasarathy S., Carew T.E., Butler S., Witztum J.L., Steinberg D. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J. Clin. Invest. 84:1989;1086-1095.
5. Hazell L.J., Arnold L., Flowers D., Waeg G., Malle E., Stocker R. Presence of hypochlorite-modified proteins in human atherosclerotic lesions. J. Clin. Invest. 97:1996;1535-1544.
6. Leeuwenburgh C., Hardy M.M., Hazen S.L., Wagner P., Oh-ishi S., Steinbrecher U.P., Heinecke J.W. Reactive nitrogen intermediates promote low density lipoprotein oxidation in human atherosclerotic intima. J. Biol. Chem. 272:1997;1433-1436.
7. Hazen S.L., Heinecke J.W. 3-Chlorotyrosine, a specific marker of myeloperoxidase-catalyzed oxidation, is markedly elevated in low density lipoprotein isolated from human atherosclerotic intima. J. Clin. Invest. 99:1997;2075-2081.
8. Burton G.W., Ingold K.U. Vitamin E application of the principles of physical organic chemistry to the exploration of its structure and function . Acc. Chem. Res. 19:1986;194-201.
9. Bowry V.W., Ingold K.U., Stocker R. Vitamin E in human low-density lipoprotein. When and how this antioxidant becomes a pro-oxidant. Biochem. J. 288:1992;341-344.
10. Bowry V.W., Stocker R. Tocopherol-mediated peroxidation. The pro-oxidant effect of vitamin E on the radical-initiated oxidation of human low-density lipoprotein. J. Am. Chem. Soc. 115:1993;6029-6044.
11. Yoshida Y., Tsuchiya J., Niki E. Interaction of α-tocopherol with copper and its effect on lipid peroxidation. Biochim. Biophys. Acta. 1200:1994;85-92.
12. Witting P.K., Bowry V.W., Stocker R. Inverse deuterium kinetic isotope effect for peroxidation in human low-density lipoprotein (LDL) a simple test for tocopherol-mediated peroxidation of LDL lipids . FEBS Lett. 375:1995;45-49.
13. Thomas S.R., Neuzil J., Stocker R. Co-supplementation with coenzyme Q prevents the pro-oxidant effect of α-tocopherol and increases the resistance of low-density lipoprotein towards transition metal-dependent oxidation initiation. Arterioscler. Thromb. Vasc. Biol. 16:1996;687-696.
14. Neuzil J., Thomas S.R., Stocker R. Requirement for, promotion, or inhibition by α-tocopherol of radical-induced initiation of plasma lipoprotein lipid peroxidation. Free Radic. Biol. Med. 22:1997;57-71.
15. Esterbauer H., Striegl G., Puhl H., Rotheneder M. Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Rad. Res. Commun. 6:1989;67-75.
16. Esterbauer H., Dieber-Rotheneder M., Striegl G., Waeg G. Role of vitamin E in preventing the oxidation of low-density lipoprotein. Am. J. Clin. Nutr. 53:1991;314S-321S.
17. Dieber-Rotheneder M., Puhl H., Waeg G., Striegl G., Esterbauer H. Effect of oral supplementation with D-alpha-tocopherol on the vitamin E content of human low density lipoproteins and resistance to oxidation. J. Lipid Res. 32:1991;1325-1332.
18. Jessup, W.; Rankin, S. M.; De Whalley, C. V.; Hoult, J. R. S.; Scott, J.; Leake, D. S. α-Tocopherol consumption during low-density lipoprotein oxidation. Biochem. J. 265:399-405; 1990.
19. Frei B., Gaziano J.M. Content of antioxidants, preformed lipid hydroperoxides, and cholesterol as predictors of the susceptibility of human LDL to metal ion-dependent and -independent oxidation. J. Lipid Res. 34:1993;2135-2145.
20. Kontush A., Hübner C., Finckh B., Kohlschütter A., Beisiegel U. Low density lipoprotein oxidizability by copper correlates to its initial ubiquinol-10 and polyunsaturated fatty acid content. FEBS Lett. 341:1994;69-73.
21. Thomas S.R., Davies M.J., Stocker R. Oxidation and antioxidation of human low-density lipoprotein and plasma exposed to 3-morpholinosydnonimine and reagent peroxynitrite. Chem. Res. Toxicol. 11:1998;484-494.
22. Ingold K.U., Bowry V.W., Stocker R., Walling C. Autoxidation of lipids and antioxidation by α-tocopherol and ubiquinol in homogeneous solution and in aqueous dispersions of lipids. The unrecognized consequences of lipid particle size as exemplified by the oxidation of human low density lipoprotein. Proc. Natl. Acad. Sci. USA. 90:1993;45-49.
23. Waldeck A.R., Stocker R. Radical-initiated lipid peroxidation in low density lipoproteins insights obtained from kinetic modeling . Chem. Res. Toxicol. 9:1996;954-964.
24. Ingold K.U., Howard J.A. Reaction of phenols with peroxy radicals. Nature. 195:1962;280-281.
25. Burton G.W., Ingold K.U. Autoxidation of biological molecules. 1. The antioxidant activity of vitamin E and related chain-breaking phenolic antioxidants in vitro. J. Am. Chem. Soc. 103:1981;6472-6477.
26. Bisby R.H., Parker A.W. Reactions of the α-tocopheroxyl radical in micellar solutions studied by nanosecond laser flash photolysis. FEBS Lett. 290:1991;205-208.
27. Massey J.B. Kinetics of transfer of α-tocopherol between model and native plasma lipoproteins. Biochim. Biophys. Acta. 793:1984;387-392.
28. Bowry V.W., Stanley K.K., Stocker R. High density lipoprotein is the major carrier of lipid hydroperoxides in fasted human plasma. Proc. Natl. Acad. Sci. USA. 89:1992;10316-10320.
29. Mohr D., Stocker R. Radical-mediated oxidation of isolated human very low density lipoprotein. Arterioscler. Thromb. 14:1994;1186-1192.
30. Upston J.M., Neuzil J., Stocker R. Oxidation of LDL by recombinant human 15-lipoxygenase evidence for α-tocopherol dependent oxidation of esterified core and surface lipids . J. Lipid Res. 37:1996;2650-2661.
31. Witting P.K., Upston J.M., Stocker R. The molecular action of α-tocopherol in lipoprotein lipid peroxidation pro- and antioxidant activity of vitamin E in complex heterogeneous lipid emulsions . Quinn P., Kagan V. Subcellular biochemistry fat-soluble vitamins . 1998;345-390 Plenum, London.
32. Lynch S.M., Frei B. Reduction of copper, but not iron, by human low density lipoprotein (LDL). Implications for metal ion-dependent oxidative modification of LDL. J. Biol. Chem. 270:1995;5158-5163.
33. Kontush A., Meyer S., Finckh B., Kohlschütter A., Beisiegel U. α-Tocopherol as a reductant for Cu(II) in human lipoproteins. Triggering role in the initiation of lipoprotein oxidation. J. Biol. Chem. 271:1996;11106-11112.
34. Proudfoot J.M., Croft K.D., Puddey I.B., Beilin L.J. The role of copper reduction by alpha-tocopherol in low-density lipoprotein oxidation. Free Radic. Biol. Med. 23:1997;720-728.
35. Garner B., van Reyk D., Dean R.T., Jessup W. Direct copper reduction by macrophages. Its role in low density lipoprotein oxidation. J. Biol. Chem. 272:1997;6927-6935.
36. Sparrow C.P., Olszewski J. Cellular oxidation of low density lipoprotein is caused by thiol production in media containing transition metal ions. J. Lipid Res. 34:1993;1219-1228.
37. Baoutina A., Dean R.T., Jessup W. α-tocopherol supplementation of macrophages does not influence their ability to oxidize LDL. J. Lipid Res. 39:1998;114-130.
38. Ziouzenkova O., Sevanian A., Abuja P.M., Ramos P., Esterbauer H. Copper can promote oxidation of LDL by markedly different mechanisms. Free Radic. Biol. Med. 24:1998;607-623.
39. Witting P.K., Upston J.M., Stocker R. The role of α-tocopheroxyl radical in the initiation of lipid peroxidation in human low density lipoprotein exposed to horse radish peroxidase. Biochemistry. 36:1997;1251-1258.
40. Hazell L.J., Stocker R. Oxidation of low-density lipoprotein with hypochlorite causes transformation of the lipoprotein into a high-uptake form for macrophages. Biochem. J. 290:1993;165-172.
41. Hawkins C.L., Davies M.J. Hypochlorite-induced damage to proteins formation of nitrogen-centered radicals from lysine residues and their role in protein fragmentation . Biochem. J. 332:1998;617-625.
42. Hazell L.J., Davies M.J., Stocker R. Secondary radicals derived from chloramines of apolipoprotein B-100 contribute to HOCl-induced lipid peroxidation of low-density lipoproteins. Biochem J. 339:1999;489-495.
43. Pryor W.A., Jin X., Squadrito G.L. One- and two-electron oxidations of methionine by peroxynitrite. Proc. Natl. Acad. Sci. USA. 91:1994;11173-11177.
44. Bowry V.W., Mohr D., Cleary J., Stocker R. Prevention of tocopherol-mediated peroxidation of ubiquinol-10-free human low density lipoprotein. J. Biol. Chem. 270:1995;5756-5763.
45. Thomas S.R., Neuzil J., Mohr D., Stocker R. Co-antioxidants make α-tocopherol an efficient antioxidant for LDL. Am. J. Clin. Nutr. 62:1995;1357S-1364S.
46. Neuzil J., Witting P.K., Stocker R. α-Tocopheryl hydroquinone is an efficient multifunctional inhibitor of radical-initiated oxidation of low-density lipoprotein lipids. Proc. Natl. Acad. Sci. USA. 94:1997;7885-7890.
47. Sato K., Niki E., Shimasaki H. Free radical-mediated chain oxidation of low density lipoprotein and its synergistic inhibition by vitamin E and vitamin C. Arch. Biochem. Biophys. 279:1990;402-405.
48. Kagan V.E., Serbinova E.A., Forte T., Scita G., Packer L. Recycling of vitamin E in human low density lipoproteins. J. Lipid Res. 33:1992;385-397.
49. Thomas S.R., Witting P.K., Stocker R. 3-Hydroxyanthranilic acid is an efficient, cell-derived co-antioxidant for α-tocopherol, inhibiting human low density lipoprotein and plasma lipid peroxidation. J. Biol. Chem. 271:1996;32714-32721.
50. Mohr D., Bowry V.W., Stocker R. Dietary supplementation with coenzyme Q10 results in increased levels of ubiquinol-10 within circulating lipoproteins and increased resistance of human low density lipoprotein to the initiation of lipid peroxidation. Biochim. Biophys. Acta. 1126:1992;247-254.
51. Upston J.M., Neuzil J., Witting P.K., Alleva R., Stocker R. 15-Lipoxygenase-induced enzymic oxidation of low density lipoprotein associated free fatty acids stimulates nonenzymic, α-tocopherol-mediated peroxidation of cholesteryl esters. J. Biol. Chem. 272:1997;30067-30074.
52. Hazell L.J., Stocker R. α-Tocopherol does not inhibit hypochlorite-induced oxidation of apolipoprotein B-100 of low-density lipoprotein. FEBS Lett. 414:1997;541-544.
53. Frei B., Stocker R., Ames B.N. Antioxidant defenses and lipid peroxidation in human blood plasma. Proc. Natl. Acad. Sci. USA. 85:1988;9748-9752.
54. Cleary J., Mohr D., Adams M.R., Celermajer D.S., Stocker R. Plasma and LDL levels of major lipophilic antioxidants are similar in patients with advanced atherosclerosis and healthy controls. Free Radic. Res. 26:1997;175-182.
55. Heinecke J.W. Mass spectrometric quantification of amino acid oxidation products in proteins insights into pathways that promote LDL oxidation in the human artery wall . FASEB J. 13:1999;1113-1120.
56. Ylä-Herttuala S., Rosenfeld M.E., Parthasarathy S., Glass C.K., Sigal E., Witztum J.L., Steinberg D. Colocalization of 15-lipoxygenase mRNA and protein with epitopes of oxidized low density lipoprotein in macrophage-rich areas of atherosclerotic lesions. Proc. Natl. Acad. Sci. USA. 87:1990;6959-6963.
57. Smith C., Mitchinson M.J., Aruoma O.I., Halliwell B. Stimulation of lipid peroxidation and hydroxyl-radical generation by the contents of human atherosclerotic lesions. Biochem. J. 286:1992;901-905.
58. Fu S., Davies M.J., Stocker R., Dean R.T. Evidence for roles of radicals in protein oxidation in advanced human atherosclerotic plaque. Biochem. J. 333:1998;519-525.
59. Leeuwenburgh C., Rasmussen J.E., Hsu F.F., Mueller D.M., Pennathur S., Heinecke J.W. Mass spectrometric quantification of markers for protein oxidation by tyrosyl radical, copper, and hydroxyl radical in low density lipoprotein isolated from human atherosclerotic plaques. J. Biol. Chem. 272:1997;3520-3526.
60. Hoff H.F., Heideman C.L., Gotto A.M., Gaubatz J.W. Quantitation of apoliporotein B in grossly normal and atherosclerotic human aorta. Circ. Res. 41:1977;684-690.
61. Carpenter K.L., Cheeseman K.H., van der Veen C., Taylor S.E., Walker M.K., Mitchinson M.J. Depletion of alpha-tocopherol in human atherosclerotic lesions. Free Radic. Res. 23:1995;549-558.
62. Suarna C., Dean R.T., May J., Stocker R. Human atherosclerotic plaque contains both oxidized lipids and relatively large amounts of α-tocopherol and ascorbate. Arterioscler. Thromb. Vasc. Biol. 15:1995;1616-1624.
63. Niu X., Zammit V., Upston J.M., Dean R.T., Stocker R. Co-existence of oxidized lipids and α-tocopherol in all lipoprotein fractions isolated from advanced human atherosclerotic plaques. Arterioscler. Thromb. Vasc. Biol. 19:1999;1708-1718.
64. Porter N.A., Caldwell S.E., Mills K.A. Mechanisms of free radical oxidation of unsaturated lipids. Lipids. 30:1995;277-290.
65. Kenar J.A., Havrilla C.M., Porter N.A., Guyton J.R., Brown S.A., Klemp K.F., Selinger E. Identification and quantification of the regioisomeric cholesteryl linoleate hydroperoxides in oxidized human low density lipoprotein and high density lipoprotein. Chem. Res. Toxicol. 9:1996;737-744.
66. Brooks C.J.W., Harland W.A., Steel G., Gilbert J.D. Lipids of human atheroma isolation of hydroxyoctadecadienoic acids from advanced aortal lesions . Biochim. Biophys. Acta. 202:1970;563-566.
67. Upston J.M., Terentis A.C., Stocker R. Tocopherol-mediated peroxidation (TMP) of lipoproteins implications for vitamin E as a potential antiatherogenic supplement . FASEB J. 13:1999;977-994.
68. Washko P.W., Wang Y., Levine M. Ascorbic acid recycling in human neutrophils. J. Biol. Chem. 268:1993;15531-15535.
69. Witting P.K., Pettersson K., Östlund-Lindqvist A.-M., Westerlund C., Westin Eriksson A., Stocker R. Inhibition by a co-antioxidant of aortic lipoprotein lipid peroxidation and atherosclerosis in apolipoprotein E and low density lipoprotein receptor gene double knockout mice. FASEB J. 13:1999;667-675.
70. Witting P.K., Peterson K., Ostlund-Lindqvist A.-M., Westerlund C., Wagberg M., Stocker R. Dissociation of atherogenesis from aortic accumulation of lipid hydroperoxides in Watanabe heritable hyperlipidemic rabbits. J. Clin. Invest. 104:1999;213-220.
71. Björkhem I., Henriksson-Freyschuss A., Breuer O., Diczfalusy U., Berglund L., Henriksson P. The antioxidant butylated hydroxytoluene protects against atherosclerosis. Arterioscler. Thromb. 11:1991;15-22.
72. Sparrow C.P., Doebber T.W., Olszewski J., Wu M.S., Ventre J., Stevens K.A., Chao Y.S. Low density lipoprotein is protected from oxidation and the progression of atherosclerosis is slowed in cholesterol-fed rabbits by the antioxidant N,N′-diphenyl-phenylenediamine. J. Clin. Invest. 89:1992;1885-1891.
73. Cynshi O., Kawabe Y., Suzuki T., Takashima Y., Kaise H., Nakamura M., Ohba Y., Kato Y., Tamura K., Hayasaka A., Higashida A., Sakaguchi H., Takeya M., Takahashi K., Inoue K., Noguchi N., Niki E., Kodama T. Antiatherogenic effects of the antioxidant BO-653 in three different animal models. Proc. Natl. Acad. Sci. USA. 95:1998;10123-10128.
74. Witting P.K., Westerlund C., Stocker R. A rapid and simple screening test for potential inhibitors of tocopherol-mediated peroxidation of LDL lipids. J. Lipid Res. 37:1996;853-867.
75. Watson A.D., Leitinger N., Navab M., Faull K.F., Horkko S., Witztum J.L., Palinski W., Schwenke D., Salomon R.G., Sha W., Subbanagounder G., Fogelman A.M., Berliner J.A. Structural identification by mass spectrometry of oxidized phospholipids in minimally oxidized low density lipoprotein that induce monocyte/endothelial interactions and evidence for their presence in vivo. J. Biol. Chem. 272:1997;13597-13607.
76. Lynch S.M., Morrow J.D., Roberts L.J. II, Frei B. Formation of noncyclooxygenase-derived prostanoids (F2-isoprostanes) in plasma and low-density lipoprotein exposed to oxidative stress in vitro. J. Clin. Invest. 93:1994;998-1004.
77. Stocker R. The ambivalence of vitamin E in atherogenesis. Trends Biochem. Sci. 24:1999;219-223.
78. Pratico D., Tangirala R.K., Radar D., Rokach J., FitzGerald G.A. Vitamin E suppresses isoprostane generation in vivo and reduces atherosclerosis in apoE-deficient mice. Nat. Med. 4:1998;1189-1192.